kurdistan aid fund
Kurdistan Aid Fund
Following multiple requests for humanitarian assistance in the refugee/IDP crisis within Iraqi Kurdistan, ABS Community Research established “Kurdistan Aid Fund” as a special giving program to raise funds for the purchasing and deployment of requested products and services, through partnerships with Kurdish business leaders, US experts, and fundraising collaboratives.
Medical supplies and medicines are deployed through partnerships with Kurdish health organizations lead by Kurdish-European medical group Savrina, Co., Ltd (www.savrina.eu) who is working with the Kurdistan Regional Government. This public-private partnership provides medical assistance to the public hospitals in the Kurdish region of Iraq that are overflowing with the refugee and internal displacement crisis. Medicines and medical supplies are provided through US FDA approved partners via MedVet Supply, LLC which currently serves Veterans Administration Hospitals with generic medicines throughout the United States.
Kurdistan Aid Fund is a special giving program to provide medicines and health products, water supply, medical equipment and clinics to the Iraqi IDP and Syrian refugee crisis in the Kurdish region of Iraq.
According to reports, there are over 1.5 million Syrian and Iraqi refugees and IDPs in Iraqi Kurdistan. Over 1000 sites in Kurdistan are hosting IDPs, and 64% of the internally displaced have sought refuge in the Dohuk governate. 150 schools in Duhok province accommodate over 25,000 families, while others stay in halls and unfinished buildings. Others are in churches, mosques, parks and shells of apartment buildings without water or electricity. Three camps are in process of being developed, but many more are needed.
The overload of displaced persons in the Kurdish region has gravely outweighed local capacity to address the widespread needs including shelters, electricity, medicines, healthcare, water, nonperishable food, and blankets especially as these women and children without shelter are facing life-threatening elements.
In Kurdistan, over 1.5 million persons are added in patient demand due to the refugee and IDP crisis. Public hospitals are overflowing with patients, and mobile medical units are overwhelmed. In response to the refugee/IDP health crisis, Kurdistan Aid Fund developed a medical assistance program, specifically to address medical assistance requests in consideration also to Kurdistan’s need for advanced health infrastructure.
Following multiple requests for humanitarian assistance in the refugee/IDP crisis within Iraqi Kurdistan, ABS Community Research established “Kurdistan Aid Fund” as a special giving program to raise funds for the purchasing and deployment of requested products and services, through partnerships with Kurdish health organizations, US experts, and fundraising collaboratives. Kurdistan Aid Fund works with health partner Savrina, Co., Ltd. in Kurdistan, representing the KRG Ministry of Health, and their special requests of humanitarian aid in this time of crisis.
Kurdistan Aid Fund has been involved in advocacy for the refugee crisis in the Kurdish region of Iraq since 2011, including multiple feasibility study and partnership development visits on location in Iraq and at refugee camps, and multiple fundraising collaboratives. Kurdistan Aid Fund is currently working with an energy partnership group on allocating regular dedicated proceeds through energy trading.
Through the Veterans1 partnership, Kurdistan Aid Fund addresses the growing refugee crisis in northern Iraq by engaging advocacy and philanthropy to provide medical assistance (medicines, medical training, equipment, clinics). In addition, with the support of Brig. Gen. Ernie Audino (US Army, Ret.), ABS works with Veterans1 on educating Americans on the culture and history of the Kurdish people, the history of US alliance in the Kurdish region, and the significance of Iraqi and Iraqi Kurdish leadership to the US-Iraq alliance. This includes education on the groundbreaking advocacy by Ambassador Peter Galbraith for the Kurdish people and standing firm to oppose genocidal attacks against Kurds.
Health Crisis Among Refugees and IDPs
In a recent public statement, the Kurdistan Regional Government (KRG) Ministry of Health openly requests international health organizations “to provide medicine and medical equipment to ensure necessary vaccination and health services reach all internally displaced people, particularly in the Governorate of Duhok.” The statement continues:
“Dr. Dara Koshnaw, Director General at the KRG Ministry of Health, told KRG.org that health conditions in the refugee camps are fair and no disease outbreaks have so far been reported. However, he said, ‘The situation remains alarming due to sanitation and the bad hygienic situation.’ He added that the Ministry of Health is ‘taking all possible measures to minimize the risk of the spread of epidemic diseases. In order for the displaced Iraqis and Syrian refugees to more easily access health services, the Ministry of Health has made sure that the hospitals and health centers in the Duhok governorate are available to these groups free of charge.’… He added that their teams also provide ‘effective and timely treatment of any reported case to prevent the possibility of any epidemic disease from spreading’.”
“Dr Khoshnaw lauded the role of international health organisations for the support they have provided thus far to the Kurdistan Region. However, he warned that more help is needed. He also called on donor countries and other organisations to provide more medicines and medical equipment, especially antibiotics, analgesics, anesthesia, but also medicines for chronic diseases, diabetes mellitus, hypertension, heart failure and hepatitis.”
During preliminary visits to the Dormis camp in the Dohuk governate for Syrian refugees, multiple volunteer physicians and nurses, plus lead physician at Doctors Without Borders medical clinic reported that there is less than 10% of the medicines and health products needed to serve the refugee/IDP crisis. They also reported daily transports of refugees to public hospitals in the urban areas, which is overwhelming local capacities. The above images exhibit the total product supply for 60,000 refugees, including women and children. This stock is a mere fraction of what one pharmacy would have, whereas in a small American town with the same population would have at least five (5) pharmacies and ten (10) medical facilities serving the same population size.
For initial efforts towards establishing Kurdistan Aid Fund, medical leadership from Dohuk Technical Institute outlined a series of pharmaceuticals and supplements which medical providers were restricted from obtaining due to financial limitations of the refugee/IDP crisis. ABS maintained a pledge to effectively raise funds to purchase and deploy health products to treat the following top illnesses which the physicians reported of concern, especially with regards to ailments during the winter.
- Upper & lower respiratory tract infections (Tonsillitis, Pharyngitis, Laryngitis, Sinusitis, Rhinitis, Otitis Media, Bronchitis & Asthma)
- Diarrhea (Bacterial, Giardiasis & Amaebiasis)
- Dermatological (Fungal, Scabees, Eczyma)
- Musculoskeletal & Traumatic
- Diabetes Mellitis
- Hypertension & Cardiac
- Mumps, Measles
Medicines, health products, and related medical supplies are provided through ABS partners that serve US Veterans Administration Hospitals, 150 pharmacies in the United States, and is a US corporation in partnership also with FDA approved production, repackaging and distribution facilities internationally. Through health partnerships, generic health products are obtained through discount prices, purchased and shipped by Kurdistan Aid Fund on behalf of Savrina Co Ltd. In addition, Kurdistan Aid Fund works with corporate pharmaceutical foundations which donate medicines through this program.
As part of the medical assistance initiative, Kurdistan Aid Fund also makes stipends for pharmacological professors and leading medical providers, as core to the Medical Adherence program. This program provides training, oversight, and regular reporting on distribution and usage of medical products provided.